The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Teva Pharmaceutical Industries Ltd

NYSE: TEVA
Last

(U.S.) $32.61

Today's change+0.08 +0.25%
Updated March 22 4:02 PM EDT. Delayed by at least 15 minutes.
 

Teva Pharmaceutical Industries Ltd

NYSE: TEVA
Last

(U.S.) $32.61

Today's change+0.08 +0.25%
Updated March 22 4:02 PM EDT. Delayed by at least 15 minutes.

Teva Pharmaceutical Industries Ltd up (U.S.)$0.08

Teva Pharmaceutical Industries Ltd closed up Wednesday by (U.S.)$0.08 or 0.25% to (U.S.)$32.61. Over the last five days, shares have lost 5.04% and sit 2.23% above their 52-week low. This security has underperformed the S&P 500 by 55.04% during the last year.

Key company metrics

  • Open(U.S.) $32.60
  • Previous close(U.S.) $32.53
  • High(U.S.) $32.68
  • Low(U.S.) $32.16
  • Bid / Ask(U.S.) $32.51 / (U.S.) $32.68
  • YTD % change-10.04%
  • Volume5,526,216
  • Average volume (10-day)5,993,339
  • Average volume (1-month)10,387,972
  • Average volume (3-month)10,378,829
  • 52-week range(U.S.) $31.90 to (U.S.) $58.16
  • Beta0.62
  • Trailing P/E210.50×
  • P/E 1 year forward6.81×
  • Forward PEG2.76×
  • Indicated annual dividend(U.S.) $1.36
  • Dividend yield4.17%
  • Trailing EPS(U.S.) $0.15
Updated March 22 4:02 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue6,4925,5635,0384,810
Total other revenue--------
Total revenue6,4925,5635,0384,810
Gross profit3,3902,8012,8772,791
Total cost of revenue3,1022,7622,1612,019
Total operating expense6,6294,7984,6773,645
Selling / general / administrative1,4401,2501,2631,143
Research & development684663375389
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1,50872079231
Other operating expenses, total-105-5978663
Operating income-1377653611,165
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-914615256867
Income after tax-971408227639
Income tax, total5720729228
Net income-973412254636
Total adjustments to net income-65-64-66-66
Net income before extra. items-973412254636
Minority interest12123
Equity in affiliates-3215-6
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1,038348188570
Inc. avail. to common incl. extra. items-1,038348188570
Diluted net income-1,038348188570
Dilution adjustment0000
Diluted weighted average shares1,015984920920
Diluted EPS excluding extraordinary itemsvalue per share-1.020.350.200.62
Dividends per sharevalue per share0.340.340.340.34
Diluted normalized EPSvalue per share-0.060.840.970.64